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The main etiology of ankle osteoarthrosis is post-traumatic and its prevalence is highest
among  young individuals. Thus, this disease has a great socioeconomic impact and gives rise
to signiﬁcant losses of patients’ quality of life. The objective of its treatment is to eliminate
pain  and keep patients active. Therefore, the treatment should be staged according to the
degree  of degenerative evolution, etiology, joint location, systemic condition, bone quality,
lower-limb  alignment, ligament stability and age. The treatment algorithm is divided into
non-surgical therapeutic methods and options for surgical treatment. Joint preservation,
joint  replacement and arthrodesis surgical procedures have precise indications. This article
presents a review on this topic and a proposal for a treatment algorithm for this disease.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda.  
Lesão  de  cartilagem  e  osteoartrose  do  tornozelo:  revisão  da  literatura  e
algoritmo  de  tratamento
alavras-chave:
steoartrite
r  e  s  u  m  o
A principal etiologia da osteoartrose (OA) do tornozelo é pós-traumática e sua maior
prevalência  está entre indivíduos jovens; assim, essa doenc¸a  apresenta grande impacto
Este é um artigo Open Access sob a licença de CC BY-NC-NDornozelo socioeconômico  e signiﬁcativo prejuízo na qualidade de vida dos pacientes. O objetivo do
steotomiartroplastia
rtrodese
tratamento é eliminar a dor e manter os pacientes ativos. Dessa forma, o tratamento deve
ser  estagiado de acordo com o grau de evoluc¸ão  da degenerac¸ão,  a etiologia, a localizac¸ão
articular,  a condic¸ão  sistêmica, a qualidade óssea, o alinhamento do membro inferior, a
estabilidade ligamentar e a idade. O algoritmo de tratamento é dividido nas modalidades
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de terapia não cirúrgicas e nas opc¸ões  de tratamento cirúrgico. As cirurgias de preservac¸ão
articular,  as cirurgias de substituic¸ão  articular e as artrodeses apresentam indicac¸ões  pre-
cisas. O presente artigo apresenta uma revisão sobre o tema e uma  proposta de algoritmo
de tratamento para essa doenc¸a.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Osteoarthrosis (OA) is a syndrome characterized by degen-
eration  of the joint cartilage, alterations to subchondral
bone, intra-articular inﬂammatory alterations and periartic-
ular  bone growth, and it causes pain and functional loss in
the  affected limb.1–3 There is still no effective cure for this syn-
drome  today, through any methods for prevention, diminution
of  its progression or treatment of symptoms that have been
proposed.1,2,4,5
OA affects 15% of the worldwide adult population, which
makes  it a disease of high socioeconomic impact both for
individuals  and for all of society.6 For example, in the United
States,  this represents annual costs of 60 billion dollars for the
direct  treatment.1,6,7
The most important universal risk factors are age, exces-
sive  joint loading, joint injuries, fractures and ligament
injuries.1,6
OA of the tibiotarsal joint is present in 4.4% of the patients
who  seek orthopedic attendance because of OA of the lower
limbs.
Differently  from hip joint degeneration (58%) and knee joint
degeneration (67%), OA of the ankle is of primary origin in only
9%  of the cases. The secondary causes (rheumatoid arthritis,
hemochromatosis, hemophilia or osteonecrosis) are present
in  13% of the cases. The main etiology is post-traumatic and
this  is the reason for tibiotarsal joint degeneration in 78% of
the  cases, while fractures around the ankle are the cause in
62%  and ligament injuries are the cause in 16%.7–9
Individuals with ankle arthrosis tend to be younger than
other  patients with joint degeneration in the lower limbs and
present  faster functional loss, with progression to the ﬁnal
stages  of the disease between 10 and 20 years after the start
of  the lesion.9
Physiopathogenesis
A variety of anatomical and biomolecular characteristics of
the  ankle are determinants for understanding the susceptibil-
ity  of the cartilage of this joint to degeneration.
The total area of the tibiotarsal joint is 350 mm2 and it is
subjected  to a force of 500 N, while the hip and knee, with joint
areas  of respectively 1100 mm2 and 1120 mm2, are subjected
to  the same force.10–12 Thus, the pressure on the joint cartilage
of  the ankle may  be up to three times greater than the pressure
on  the other joints of the lower limbs. On the other hand, the
load  distribution on the congruent joints, i.e. the ankle and
hip,  differs from the load distribution on the knee, such thatthe compressive forces are distributed over a larger area. This
possibly  allows the ankle cartilage to be thinner than that of
the  knee. The thickness of the ankle joint cartilage ranges from
1  to 1.62 mm and is thinner than that of the hip (1.35–2 mm)
and  knee (1.69–2.55 mm).13
Comparative biomolecular studies on humans have shown
that  the ankle cartilage has higher density of glycosamino-
glycan sulfate and lower modulus of equilibrium, dynamic
rigidity, water component and hydraulic permeability than
those  of the knee cartilage. The properties inﬂuence the capac-
ity  to deform under compression during the load cycle.14,15
The way in which the collagen of the ankle cartilage is
organized resembles that of the knee, but the chondrocyte dis-
tribution differs. In the ankle, in the superﬁcial layer of the
cartilage,  the chondrocytes are presented in groups.16
Along with these characteristics, the cartilage tissue of
ankles  that are subjected to injury presents increased colla-
gen  synthesis. The chondrocytes of the ankle are metabolically
more  active than those of the knee and present greater
aggrecan turnover and greater sensitivity to anabolic stimuli,
followed  by removal of interleukin-1, and greater response of
the  chondrocytes to inﬂammatory stimuli.17–20
The following are also determinants for the physiopatho-
genesis: poor structural or acquired alignments of the lower
limb,  muscle imbalance and weakness around the tibiotarsal
joint,  age, gender, ethnicity and genetic predisposition.2,6
Diagnosis  and  classiﬁcation  system
The clinical presentation consists of pain in the region of
the  joint interline, with or without an associated increase in
volume  (joint effusion) and limitations on the range of joint
motion,  functioning, work and recreational activities. These
conditions  may  diminish the quality of life of individuals with
diseases  like hip OA, dialytic kidney failure, congestive heart
failure  or radiculopathy.21 Other associated clinical alterations
include  leg muscle atrophy and alterations to gait patterns,
particularly changes to kinematics and kinetics.22–25
The initial investigation by means of imaging is conducted
using  radiographs with weight-bearing. These may  show dif-
ferent degrees if diminution of the joint space and formation
of  osteophytes, sclerosis and subchondral cysts. The Morrey
and  Wiedeman classiﬁcation system is based on these radio-
graphic  ﬁndings.26,27
Magnetic resonance imaging (MRI) is the most sensitive
and speciﬁc noninvasive imaging examination for evaluating
the  joint cartilage. By means of speciﬁc protocols for image
acquisition and analysis, it also enables access to the mor-
phology  and biochemical composition of this tissue.28
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Stage I
Stage II
Stage III
Stage IV
Nonsurgical treatment
Insoles
Modification of footwear characteristics
Analgesics and anti-inflammatory agents
condroprotetores 
Corrective osteotomy: simple or combined
Ligament repair and reconstruction
Tenoplasty and tendon transfer
Corrective surgery on the osteochondral lesion
arthrodiastasis
Joint preservation surgery
Three components
Constrained or unconstrained
Heterologous transplantation
Total ankle arthroplasty
Open or arthroscopic
Single or combined
Retrograde intramedullary rod
Plate
Screws
Ankle arthrodesis
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Determining the precise location, size of the area affected
nd  depth of the cartilaginous lesion is fundamental in select-
ng  the treatment. Thus, MRI  protocols aimed toward the
artilage  and equipment with bigger magnetic ﬁelds (three
o  seven Tesla) provide a better view of the cartilage and the
ssociated  lesions.29–32
New MRI  techniques for studying the cartilage, such as
olumetric quantitative analysis, dGEMRIC mapping, T1-rho
apping,  T2 mapping and MRI  using sodium-23, enable
ccess  to the microstructure and, indirectly, to fundamen-
al  characteristics of the ankle cartilage, thereby improving
he  diagnosis and treatment of chondral and osteochondral
esions.30–33
Recently, the SPECT technique made it possible to correlate
he  morphological and biochemical information in investigat-
ng  ankle OA and was  shown to be useful for locating the active
egeneration, especially in areas in which the number and the
onﬁguration  of the joint are complex.34–36
lgorithm  for  staged  treatment
he decision on which treatment to use depends on the
ntensity  of the pain, functional limitation, degree of joint
egeneration, etiology, joint location, systemic condition,
one  quality, lower-limb alignment, ligament stability and age,
ollowing the stages proposed through the treatment algo-
ithm  (Fig. 1).
tage  I.  Nonsurgical  treatment
onsurgical treatment is mainly indicated for patients with
ild  to moderate OA, mild pain, slight functional limitations,
ny  etiology, good bone quality, adequate lower-limb align-
ent  and stable joints, of any age group.
The objectives are to improve the symptoms, maintain the
emaining  joint range of motion and provide the conditions
or  appropriate future surgical treatment.
races  and  insoles
races and insoles should be used to keep the joint in the
eutral  position during walking movements. Some braces
lso  limit ankle mobility in the sagittal plane and thus
educe the joint instability and overloading on the injured
artilage.37
Although some studies have shown satisfactory results
rom  use of corrective insoles for treating knee OA (to pro-
uce  varus deformity),38,39 this has not been seen in treating
nkle  OA.37,40
nalgesics  and  anti-inﬂammatory  agents
nalgesics and anti-inﬂammatory agents present proven
ffects  relating to pain, and the latter also shows additional
elief  relating to active OA.
However, because of the various systemic side effects and
lso  because progression of the degeneration is not avoided,
hese  medications are not used as long-term solutions.Fig. 1 – Staged treatment algorithm.
Physiotherapy
In cases of mild to moderate ankle OA, physiotherapy may
help  to preserve the range of motion and may  increase the
dynamic  joint stability through muscle strengthening. This
is  useful until the time of future treatment with total ankle
arthroplasty.8
Viscosupplementation
Interest in using intra-articular viscosupplementation with
hyaluronic  acid in the ankle, as a treatment option for joint
degeneration, has been increasing signiﬁcantly.41
In patients with OA, chondrocytes and synovial cells pro-
duce  increased levels of inﬂammatory cytokines, such as
interleukin  1 (IL-1) and tumor necrosis factor alpha (TNF-
).  In turn, these decrease collagen synthesis and increase
the  levels of catabolic mediators such as metalloproteinases
(MMPs) and other inﬂammatory mediators like interleukin 8
(IL-8), interleukin 6 (IL-6), prostaglandin E2 (PGE2) and nitric
oxide  (NO).42,43 One key protein in the pathological process of
OA  is CD44, which is found on the surfaces of chondrocytes,
synovioblasts and macrophages. CD44 is capable of inhibi-
ting  the synthesis of inﬂammatory cytokines when bound toHyaluronic acid is an important modulator, especially
through interaction with CD44 receptors that are present in
p . 2 0 568  r e v b r a s o r t o 
ﬁbroblast-like synoviocytes.45 Therefore, in addition to the
mechanical  effects of promoting better distribution of forces,
decreasing  the pressure on the chondrocytes46 and recovering
the  rheological properties of the synovial ﬂuid,47 hyaluronic
acid  acts biochemically to diminish the gene expression of the
cytokines  and the enzymes associated with OA, the produc-
tion  of prostaglandins and the intra-articular concentration
of  metalloproteinases.46,48
Mei-Dan et al.49 studied 16 patients with symptomatic OA
in  the ankle who  received intra-articular injections of 25 mg  of
sodium  hyaluronate for ﬁve consecutive weeks. There was  a
20% improvement in range of motion and a signiﬁcant reduc-
tion  in pain, as assessed using a visual analog scale and
scorings  for the ankle and hindfoot.
Sun et al.50 observed improvements in pain and ankle func-
tioning  in a series of 50 patients with ankle arthrosis who were
treated  with three intra-articular injections of hyaluronic acid
per week. Another prospective case series revealed that Hylan
GF  20 was  effective for signiﬁcantly reducing the pain associ-
ated  with ankle OA. This effect seemed to last even beyond six
to seven months after the treatment.51
The safety seems to be similar to that of the applications
that are widely used in treating OA in several other joints, such
as  the knee, hip, shoulder and hand.51–56
Findings from meta-analyses have suggested that intra-
articular viscosupplementation with hyaluronic acid can
signiﬁcantly reduce pain in patients with ankle OA, in com-
parison  with the state before the treatment, and that this
treatment  option is superior to other conservative therapies
in  patients with symptoms. However, there is no consensus
regarding the total number of injections and the volume per
dose,  in relation to the therapeutic results.57
Stage  II.  Joint  preservation  surgery
Joint preservation surgery is mainly indicated for patients with
moderate  OA presenting daily pain of signiﬁcant intensity and
mild  to moderate functional limitation, of post-traumatic or
primary etiology, with good bone quality, asymmetry of lower-
limb  alignment and joint instability, in a non-elderly age group
and  without systemic comorbidities.
The objectives are to reestablish the biomechanics, align-
ment  and joint stability, decelerate the evolution of the joint
degeneration and postpone procedures of a more  invasive
nature.
Joint  debridement
There is controversy regarding the value of joint debride-
ment  for treating ankle OA.58 Studies conducted among
patients with knee arthrosis have indicated that joint lavage
and  debridement in the absence of mechanical causes that
would  justify the procedure only provide short-term pain
relief.59,60 Thus, there is greater evidence that debridement
that addresses all the concomitant factors involved in the
etiology  of OA (removal of osteophytes and loose bodies,
resection of scar and hypertrophic synovial tissue and repair
techniques  for focal osteochondral cartilage defects) presents1 4;4 9(6):565–572
improvements in pain, edema and stiffness over the short and
medium  terms.58,61,62
Arthroscopic  joint  debridement
Speciﬁc lesions associated with OA, such as osteophytes, loose
bodies  and chondral defects, can be treated by means of
arthroscopy. However, these present worse results than do
other  diagnoses.60,61
Arthrodiastasis
It is believed that application of traction to a joint may  improve
nutrition  and the repair properties, through withdrawal of the
load.  This is done by means of external ﬁxators, which enable
removal  of traction on the joint line, with maintenance of joint
movement,  which has positive effects on the joint ﬂuid pres-
sure.  Aldegheri et al.62 described this procedure in 1979, for
treating  degenerative lesions of the hip in young patients.
Some  studies have shown satisfactory results with type of
approach  in small case series,63–66 but this option has to be
understood as a non-deﬁnitive procedure that has the aim
of  postponing arthroplasty or arthrodesis of the ankle. It is
indicated  for young patients.
Osteotomies
In patients with asymmetry of alignment of the lower limbs
(either  varus or valgus) associated ankle OA,  realignment
surgery provides an alternative to fusion or arthroplasty in
selected  cases.
Osteotomies can be simple (tibia and ﬁbula) or com-
bined (leg and heel), with or without associated soft-tissue
procedures.67
The aims are to transfer the weight from areas with dam-
aged  cartilage to areas with good-quality cartilage; to improve
the  joint congruence; to decelerate the progression of the OA;
and  to reduce the pain.
Pagenstert  et al.67 found that there was  an improvement in
the  AOFAS score over a ﬁve-year follow-up on 35 consecutive
patients with post-traumatic OA who were  treated by means
of  realignment of the leg and hindfoot.
Precise selection of the patients and adequate correction of
the  joint alignment angle are crucial to success.68,69
Treatment  of  osteochondral  lesions
Repair of focal osteochondral cartilage defects.
Microfractures
The microfracture procedure consists of making small drill
holes  in the subchondral bone after regularization of the
lesion,  in association with removal of the calciﬁed layer of the
joint  cartilage. This procedure follows the principle of obtain-
ing  a coagulum formed by mesenchymal cells originating from
the  bone marrow.
More  recently, some centers have followed the same line
of  reasoning as in the microfracture procedure and have used
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oncentrates of bone marrow aspirate (which contain mes-
nchymal  cells) but without attacking the subchondral bone.
hese  procedures are under development and under evalua-
ion.  The logic behind these procedures is based on obtaining a
luripotent cell content that is theoretically at a concentration
reater than through microfracturing, but without attacking
he  subchondral bone. Studies on animals have demonstrated
hat  superior repair tissue is formed70 and have compared
se of bone marrow aspirate concentrate with microfrac-
uring. Furthermore, several clinical studies have reported
ccurrences of signiﬁcant alterations to subchondral bone
such  as bone cysts and osteophytes inside the lesions), after
icrofracture procedures.71,72
The factors indicating a poor prognosis from this proce-
ure  comprise lesion size greater than 1.5 cm2, which signiﬁes
iameter  greater than 1.2 cm,73 uncontained lesions and pres-
nce  of cystic lesions associated with the osteochondral
esion.74
utologous  osteochondral  transfer
steochondral transfer is based on using an osteochondral
ylinder obtained from a low-demand area, usually from the
nee:  in the intercondylar region, the lateral portion of the
rochlea  immediately proximal to the loading area of the lat-
ral  condyle or the lateral crest proximal to the trochlea.
This  procedure is indicated for lesions of up to an area
f  2 cm2, in which either the cartilage alone is affected
r  the cartilage together with the subchondral bone, as in
steochondritis dissecans. The main limiting factor for osteo-
hondral  transfer consists of morbidity in the donor area,
hich  restricts the quantity and size of the cylinders to be
sed.
utologous  implantation  of  chondrocytes
his consists of cell therapy for treating joint cartilage lesions
n  which a biopsy is ﬁrst performed in order to culture chon-
rocytes.  This cell expansion is done in the laboratory for
pproximately six weeks. In a second surgical procedure,
ebridement of the lesion and implantation of chondrocytes
re  performed. In the ﬁrst generations, this implantation was
one  using a periosteal membrane, but collagen membranes
re  now used (seeded during the surgery or using cells that
ad  previously been cultured in the membrane).
tage  III.  Total  ankle  arthroplasty
otal ankle arthroplasty (TAA) is mainly indicated for patients
ith  severe OA presenting daily pain of signiﬁcant intensity
nd  major functional limitations, of any etiology, with good
one  quality, adequate alignment or only mild asymmetry of
he  lower limbs and stable joints, in a non-elderly age group
nd  without any severe systemic comorbidities.
The aims are to restore the functional range of motion,
liminate pain and improve quality of life.The ﬁrst designs for total ankle prostheses appeared in the
970s.  Despite high failure rates experiences with the ﬁrst gen-
rations of total ankle prostheses,75 several groups continued
ith  the research and today a variety of implants that come;4 9(6):565–572  569
close  to the anatomical and functional requirements of this
joint  are available.
This  evolution has resulted in improvement of the clinical
results  and has made this procedure more  popular for treating
ankle  OA.76
Analysis of the literature indicates that the main advance
has  been the concept of “mobile support”, in which the
prosthetic components interrelate with various degrees of
freedom,  without any occurrence of joint constriction. The
third-generation prostheses, which comprise three elements
(tibial,  talar and intermediate components), have been the
most  successful of these so far.77–79
However, TAA still presents high complication rates in com-
parison  with knee and hip arthroplasty.80 The intraoperative
complications are due to difﬁculty in aligning the components
and  making the bone cuts and to fracturing of the malle-
oli.  During the postoperative period, the complications relate
to  dehiscence of the surgical incision and infection.78,81 Over
the  long term, the greatest complication is aseptic loosening
of  the tibial or talar components, followed by stress fractur-
ing,  capsule retraction and retraction of the periarticular soft
tissues.82
Thus, precise patient selection is fundamental to the suc-
cess  of this procedure.
The  contraindications include osteonecrosis, severe
peripheral vascular disease, peripheral neuropathy, recent
or  previous joint infection, severe ligament instability, major
misalignment of the lower limb and poor bone quality.8
There is also the possibility of performing complete joint
replacement by means of a fresh bipolar graft from the tibio-
tarsal  joint. This procedure is a useful option for carefully
selected patients, especially young and active individuals. It
allows pain relief and maintenance of functional joint mobil-
ity.  However, further studies on the immunological behavior
of  the transplanted cartilage in this type of procedure are
needed.83–85
Stage  IV.  Arthrodesis
Arthrodesis is mainly indicated for patients with severe OA
presenting  daily pain of signiﬁcant intensity and major func-
tional  limitation, of any etiology, with good bone quality,
adequate alignment or mild asymmetry of the lower limbs
and  stable joints, in the elderly and young adult age groups
and  with absence of severe systemic comorbidities.
The aims are to reestablish the alignment of the lower limb
and  eliminate the pain.
Tibiotarsal  and  tibiotalar-calcaneal  arthrodesis
Patients with advanced ankle OA without an indication for
total  ankle arthroplasty and those who present TAA failure
form  a group that might beneﬁt from salvage procedures con-
sisting  of tibiotarsal or tibiotalar-calcaneal arthrodesis. Many
surgical  techniques and ﬁxation materials have already been
86–88described  in the literature.
The choice between tibiotarsal or tibiotalar-calcaneal
arthrodesis will depend on the conditions of degeneration,
pain and alignment of the subtalar joint.
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This procedure generally provides good functional results
and  a high rate of symptom relief. There is no doubt that cor-
rect  positioning of the joint fusion during the operation has
a  direct impact on the clinical results achieved. Thus, valgus
angles  of 5◦, external rotation angles of 5◦-10◦ and neutral
ﬂexion-extension positions of the ankle need to be achieved.89
Its disadvantages include the time taken after the oper-
ation  to reach consolidation, painful nonunion rates, length
discrepancies between the lower limbs, chronic edema,
implant loosening and peri-implant fracturing.88,89
Final  remarks
Ankle OA is a disease that differs from other forms of arthrosis
of  the lower limbs. Its main etiological factor is joint trauma,
especially malleolar fractures, chronic ankle instability and
distal  fractures of the tibia. It affects young individuals in
the  productive age group, which results in high personal and
social  costs relating to the direct treatment of this disease,
which  usually takes a long time.
The therapeutic strategies are based on a staged treatment
algorithm and depend on a broad spectrum of related factors.
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